Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study. ...
What happened According to a filing with the Securities and Exchange Commission dated November 14, 2025, investment management firm Seldon Capital LP disclosed a new position in ACM Research ...